Hydrocortisone therapy for patients with multiple trauma: The randomized controlled HYPOLYTE study

JAMA

Volumn 305, Issue 12, 2011, Pages 1201-1209

  Roquilly, Antoine ^a   Mahe, Pierre Joachim ^a   Seguin, Philippe ^c   Guitton, Christophe ^a   Floch, Hervé ^d   Tellier, Anne Charlotte ^e   Merson, Laurent ^f   Renard, Benoît ^g,h   Malledant, Yannick ^c   Flet, Laurent ^a   Sebille, Véronique ^a,b   Volteau, Christelle ^a   Masson, Damien ^a   Nguyen, Jean Michel ^a   Lejus, Corinne ^a   Asehnoune, Karim ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c RENNES UNIVERSITY HOSPITAL   (France)

^d BREST UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

^f BORDEAUX UNIVERSITY HOSPITAL   (France)

^g General Hospital La Roche sur Yon   (France)

^h centre hospitalier Les Sables d'Olonne   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE SODIUM SUCCINATE; PLACEBO;

ADRENAL CORTEX INSUFFICIENCY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTEROID INSUFFICIENCY; CORTICOTROPIN TEST; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; HYPONATREMIA; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIPLE TRAUMA; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 79952828815     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.360     Document Type: Article

References (34)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498- 1504.
2. Bronchard R, Albaladejo P, Brezac G, et al. Early onset pneumonia: risk factors and consequences in head trauma patients. Anesthesiology. 2004;100(2):234-239. (Pubitemid 38133687)
3. Leone M, Delliaux S, Bourgoin A, et al. Risk factors for late-onset ventilator-associated pneumonia in trauma patients receiving selective digestive decontamination. Intensive Care Med. 2005;31(1):64-70. (Pubitemid 40174283)
4. Lepelletier D, Roquilly A, Demeure dit latte D, et al. Retrospective analysis of the risk factors and pathogens associated with early-onset ventilator-associated pneumonia in surgical-ICU head-trauma patients. J Neurosurg Anesthesiol. 2010;22(1):32-37.
5. Osborn TM, Tracy JK, Dunne JR, Pasquale M, Napolitano LM. Epidemiology of sepsis in patients with traumatic injury. Crit Care Med. 2004;32(11):2234-2240. (Pubitemid 39491802)
6. Annane D, Sébille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock [published correction appears in JAMA. 2008;300(14):1652]. JAMA. 2002;288(7):862-871.
7. Marik PE, Pastores SM, Annane D, et al; American College of Critical Care Medicine. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med. 2008;36(6):1937-1949.
8. Mandell LA, Wunderink RG, Anzueto A, et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44(suppl 2):S27-S72.
9. Kaufmann I, Briegel J, Schliephake F, et al. Stress doses of hydrocortisone in septic shock: beneficial effects on opsonization-dependent neutrophil functions. Intensive Care Med. 2008;34(2):344-349. (Pubitemid 351207639)
10. Keh D, Boehnke T, Weber-Cartens S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med. 2003;167(4):512-520.
11. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med. 2005;171(3):242-248.
12. Steinberg KP, Hudson LD, Goodman RB, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. 2006;354(16):1671-1684.
13. Bochicchio GV, Napolitano LM, Joshi M, McCarter RJ Jr, Scalea TM. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. J Trauma. 2001;50(5):817-820. (Pubitemid 32499604)
14. Hoover L, Bochicchio GV, Napolitano LM, et al. Systemic inflammatory response syndrome and nosocomial infection in trauma. J Trauma. 2006;61(2):310-316. (Pubitemid 44265808)
15. Hoen S, Asehnoune K, Brailly-Tabard S, et al. Cortisol response to corticotropin stimulation in trauma patients: influence of hemorrhagic shock. Anesthesiology. 2002;97(4):807-813.
16. Bratton SL, Chestnut RM, Ghajar J, et al; Brain Trauma FoundationAmerican Association of Neurological Surgeons; Congress of Neurological Surgeons; Joint Section on Neurotrauma and Critical Care, AANS/CNS. Guidelines for the management of severe traumatic brain injury [published correction appears in J Neurotrauma. 2008;25(3):276-278]. J Neurotrauma. 2007;24(suppl 1):S1-S106.
17. Cohan P, Wang C, McArthur DL, et al. Acute secondary adrenal insufficiency after traumatic brain injury: a prospective study. Crit Care Med. 2005;33(10):2358-2366. (Pubitemid 41437493)
18. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416.
19. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350(5):451-458. (Pubitemid 38133765)
20. Canadian Critical Care Trials Group. A randomized trial of diagnostic techniques for ventilator-associated pneumonia. N Engl J Med. 2006;355(25):2619-2630.
21. Hoen S, Mazoit JX, Asehnoune K, et al. Hydrocortisone increases the sensitivity to alpha1-adrenoceptor stimulation in humans following hemorrhagic shock. Crit Care Med. 2005;33(12):2737-2743. (Pubitemid 41816405)
22. Offner PJ, Moore EE, Ciesla D. The adrenal response after severe trauma. Am J Surg. 2002;184(6):649-653.
23. Webster JI, Tonelli L, Sternberg EM. Neuroendocrine regulation of immunity. Annu Rev Immunol. 2002;20:125-163. (Pubitemid 34295785)
24. Bochicchio GV, Joshi M, Bochicchio K, Tracy K, Scalea TM. A time-dependent analysis of intensive care unit pneumonia in trauma patients. J Trauma. 2004;56(2):296-301, discussion 301-303.
25. Muehlstedt SG, Richardson CJ, Lyte M, Rodriguez JL. Systemic and pulmonary effector cell function after injury. Crit Care Med. 2002;30(6):1322-1326. (Pubitemid 34620979)
26. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129(6):433-440. (Pubitemid 28428078)
27. Klompas M. The paradox of ventilator-associated pneumonia prevention measures. Crit Care. 2009;13(5):315.
28. Edwards P, Arango M, Balica L, et al; CRASH trial collaborators. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet. 2005;365(9475):1957-1959.
29. Dutton RP, Stansbury LG, Leone S, Kramer E, Hess JR, Scalea TM. Trauma mortality in mature trauma systems: are we doing better? an analysis of trauma mortality patterns, 1997-2008. J Trauma. 2010;69(3):620-626.
30. Shakur H, Roberts I, Bautista R, et al; CRASH-2 trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010; 376(9734):23-32.
31. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358(2):111-124.
32. Malerba G, Romano-Girard F, Cravoisy A, et al. Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med. 2005;31(3):388-392.
33. Jabre P, Combes X, Lapostolle F, et al; KETASED Collaborative Study Group. Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet. 2009;374(9686):293-300.
34. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350(16):1629-1638. (Pubitemid 38501164)